From the Department of Orthopaedic Surgery, Rothman Orthopaedic Institute at Thomas Jefferson University Hospital, Philadelphia, PA.
J Am Acad Orthop Surg. 2024 Dec 1;32(23):e1252-e1259. doi: 10.5435/JAAOS-D-24-00167. Epub 2024 Aug 22.
To determine prescription trends across specialties in the perioperative care of patients undergoing spine surgery from 2018 to 2021.
A range of measures, including implementation of state prescription drug monitoring programs, have been instituted to combat the opioid epidemic. Considering the continued presence of opioids for spine-related pain management, a better understanding of the patterns of opioid prescription practices may be important for future intervention.
All patients aged 18 years and older who underwent elective posterior lumbar decompression and fusion, transforaminal lumbar interbody fusion, and anterior cervical diskectomy and fusion from 2018 to 2021 were retrospectively identified. Patient demographics and surgical characteristics were collected through a Structured Query Language search and manual chart review. Opioid prescription data were collected through Pennsylvania's Prescription Drug Monitoring Program (PDMP) database and grouped into the following prescriber categories: primary care, pain management, physiatry, and orthopaedic surgery.
Of the 1,062 patients, 302 (28.4%) underwent anterior cervical diskectomy and fusion, 345 (32.4%) underwent posterior lumbar decompression and fusion, and 415 (39.1%) underwent transforaminal lumbar interbody fusion. From 2018 to 2021, there were no significant differences in total opioid prescriptions from orthopaedic surgery ( P = 0.892), primary care ( P = 0.571), pain management ( P = 0.687), or physiatry ( P = 0.391) providers. Pain management providers prescribed the most opioids between 1 year and 2 months preoperatively ( P = 0.003), between 2 months and 1 year postoperatively ( P = 0.018), and overall ( P < 0.001).
Despite increasing national awareness of the opioid epidemic and the establishment of statewide prescription drug monitoring programs, prescription rates have not changed markedly in spine patients. Pain management and primary care physicians prescribe opioids at a higher rate in the chronic periods before and after surgery, likely in part because of longitudinal relationships with these patients.
III.
Retrospective Cohort Study.
确定 2018 年至 2021 年期间接受脊柱手术的患者在围手术期护理方面的各专业处方趋势。
为了应对阿片类药物泛滥,已经实施了一系列措施,包括实施州级处方药物监测计划。考虑到脊柱相关疼痛管理中仍需要使用阿片类药物,更好地了解阿片类药物处方实践模式对于未来干预可能很重要。
回顾性地确定了 2018 年至 2021 年期间接受后路腰椎减压融合术、经椎间孔腰椎体间融合术和前路颈椎间盘切除术和融合术的所有 18 岁及以上患者。通过结构化查询语言搜索和手动图表审查收集患者人口统计学和手术特征。通过宾夕法尼亚州的处方药物监测计划(PDMP)数据库收集阿片类药物处方数据,并将其分为以下处方类别:初级保健、疼痛管理、物理医学和骨科手术。
在 1062 名患者中,302 名(28.4%)接受了前路颈椎间盘切除术和融合术,345 名(32.4%)接受了后路腰椎减压融合术,415 名(39.1%)接受了经椎间孔腰椎体间融合术。2018 年至 2021 年,骨科手术(P = 0.892)、初级保健(P = 0.571)、疼痛管理(P = 0.687)和物理医学(P = 0.391)提供者的总阿片类药物处方量没有显著差异。疼痛管理提供者在术前 1 年至 2 个月(P = 0.003)、术后 2 个月至 1 年(P = 0.018)和总体(P < 0.001)期间开具的阿片类药物最多。
尽管全国范围内对阿片类药物泛滥的认识不断提高,并且建立了全州范围的处方药物监测计划,但脊柱患者的处方率并没有明显变化。疼痛管理和初级保健医生在手术前后的慢性期开具阿片类药物的比例更高,部分原因可能是与这些患者存在纵向关系。
III。
回顾性队列研究。